{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:40:12Z","timestamp":1773063612278,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81700130"],"award-info":[{"award-number":["81700130"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81700130"],"award-info":[{"award-number":["81700130"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-87273-4","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T01:17:10Z","timestamp":1737681430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of treatment for diffuse large B-cell lymphoma using plasma D-dimer levels"],"prefix":"10.1038","volume":"15","author":[{"given":"Ruonan","family":"Shao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danchen","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beibei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqiu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangbiao","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"87273_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier, B. et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl. J. Med. 346, 235\u2013242. https:\/\/doi.org\/10.1056\/NEJMoa011795 (2002).","journal-title":"N Engl. J. Med."},{"key":"87273_CR2","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1182\/blood-2017-03-769620","volume":"130","author":"M Crump","year":"2017","unstructured":"Crump, M. et al. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood 130, 1800\u20131808. https:\/\/doi.org\/10.1182\/blood-2017-03-769620 (2017).","journal-title":"Blood"},{"key":"87273_CR3","doi-asserted-by":"publisher","unstructured":"Bento, L. et al. Screening for prognostic microRNAs Associated with Treatment failure in diffuse large B cell lymphoma. Cancers (Basel). 14 https:\/\/doi.org\/10.3390\/cancers14041065 (2022).","DOI":"10.3390\/cancers14041065"},{"key":"87273_CR4","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1093\/annonc\/mdx097","volume":"28","author":"A Younes","year":"2017","unstructured":"Younes, A. et al. International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017). Ann. Oncol. 28, 1436\u20131447. https:\/\/doi.org\/10.1093\/annonc\/mdx097 (2017).","journal-title":"Ann. Oncol."},{"key":"87273_CR5","doi-asserted-by":"publisher","first-page":"120270","DOI":"10.1016\/j.talanta.2019.120270","volume":"207","author":"N Tasi\u0107","year":"2020","unstructured":"Tasi\u0107, N., Paix\u00e3o, T. R. L. C. & Gon\u00e7alves, L. M. Biosensing of D-dimer, making the transition from the central hospital laboratory to bedside determination. Talanta 207, 120270. https:\/\/doi.org\/10.1016\/j.talanta.2019.120270 (2020).","journal-title":"Talanta"},{"key":"87273_CR6","doi-asserted-by":"publisher","unstructured":"Olson, J. D. D-dimer: an overview of Hemostasis and fibrinolysis, assays, and Clini cal applications. Adv. Clin. Chem. 69, 1\u201346, https:\/\/doi.org\/10.1016\/bs.acc.2014.12.001","DOI":"10.1016\/bs.acc.2014.12.001"},{"key":"87273_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s13193-017-0682-x","volume":"9","author":"SH Sringeri","year":"2018","unstructured":"Sringeri, S. H., Chandra, P. S. & R. R. & Role of plasma D-Dimer levels in breast Cancer patients and its correlation with clinical and histopathological stage. Indian J. Surg. Oncol. 9, 307\u2013311. https:\/\/doi.org\/10.1007\/s13193-017-0682-x (2018).","journal-title":"Indian J. Surg. Oncol."},{"key":"87273_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13019-021-01618-4","volume":"16","author":"M Ma","year":"2021","unstructured":"Ma, M. et al. The D-dimer level predicts the prognosis in patients with lung cancer: a systematic review and meta-analysis. J. Cardiothorac. Surg. 16, 243. https:\/\/doi.org\/10.1186\/s13019-021-01618-4 (2021).","journal-title":"J. Cardiothorac. Surg."},{"key":"87273_CR9","doi-asserted-by":"publisher","unstructured":"Diao, D. et al. D-dimer is an essential accompaniment of circulating tumor cells in gastric cancer. BMC Cancer. 17 https:\/\/doi.org\/10.1186\/s12885-016-3043-1 (2017).","DOI":"10.1186\/s12885-016-3043-1"},{"key":"87273_CR10","doi-asserted-by":"publisher","unstructured":"Li, W. et al. Prognostic role of pretreatment plasma D-Dimer in patients with solid tumors: a systematic review and Meta-analysis. Cell. Physiol. Biochem. 45, 1663\u20131676, https:\/\/doi.org\/10.1159\/000487734","DOI":"10.1159\/000487734"},{"key":"87273_CR11","doi-asserted-by":"publisher","first-page":"e19243","DOI":"10.1097\/md.0000000000019243","volume":"99","author":"C Liu","year":"2020","unstructured":"Liu, C., Ning, Y., Chen, X. & Zhu, Q. D-Dimer level was associated with prognosis in metastatic colorectal cancer: a Chinese patients based cohort study. Med. (Baltim). 99, e19243. https:\/\/doi.org\/10.1097\/md.0000000000019243 (2020).","journal-title":"Med. (Baltim)."},{"key":"87273_CR12","doi-asserted-by":"publisher","first-page":"e0152842","DOI":"10.1371\/journal.pone.0152842","volume":"11","author":"XW Bi","year":"2016","unstructured":"Bi, X. W. et al. High pretreatment D-Dimer levels correlate with adverse clinical features and predict poor survival in patients with natural Killer\/T-Cell lymphoma. PLoS One. 11, e0152842. https:\/\/doi.org\/10.1371\/journal.pone.0152842 (2016).","journal-title":"PLoS One"},{"key":"87273_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11596-019-2023-5","volume":"39","author":"Y Geng","year":"2019","unstructured":"Geng, Y. et al. Prognostic value of D-Dimer in patients with diffuse large B-cell lymphoma: a retrospective study. Curr. Med. Sci. 39, 222\u2013227. https:\/\/doi.org\/10.1007\/s11596-019-2023-5 (2019).","journal-title":"Curr. Med. Sci."},{"key":"87273_CR14","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s12253-011-9493-5","volume":"18","author":"Z Nagy","year":"2012","unstructured":"Nagy, Z. et al. D-Dimer as a potential prognostic marker. Pathol. Oncol. Res. 18, 669\u2013674. https:\/\/doi.org\/10.1007\/s12253-011-9493-5 (2012).","journal-title":"Pathol. Oncol. Res."},{"key":"87273_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3892\/br.2018.1151","volume":"9","author":"H Dai","year":"2018","unstructured":"Dai, H. et al. D-dimer as a potential clinical marker for predicting metastasis and progression in cancer. Biomed. Rep. 9, 453\u2013457. https:\/\/doi.org\/10.3892\/br.2018.1151 (2018).","journal-title":"Biomed. Rep."},{"key":"87273_CR16","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/ijgo.12949","volume":"147","author":"L Chen","year":"2019","unstructured":"Chen, L. et al. Diagnostic value of serum D-dimer, CA125, and neutrophil-to-lymphocyte ratio in differentiating ovarian cancer and endometriosis. Int. J. Gynecol. Obstet. 147, 212\u2013218. https:\/\/doi.org\/10.1002\/ijgo.12949 (2019).","journal-title":"Int. J. Gynecol. Obstet."},{"key":"87273_CR17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.urolonc.2022.06.016","volume":"40","author":"K Yukihiro","year":"2022","unstructured":"Yukihiro, K. et al. Impact of modified Glasgow prognostic score on predicting prognosis and modification of risk model for patients with metastatic renal cell carcinoma treated with first line tyrosine kinase inhibitor. Urol. Oncol. 40, 455. .e411-455.e418 (2022).","journal-title":"Urol. Oncol."},{"key":"87273_CR18","doi-asserted-by":"publisher","unstructured":"Liao, C. K. et al. Prognostic value of the C-reactive protein to albumin ratio in colorec tal cancer: an updated systematic review and meta-analysis. World J. Surg. Oncol. 19, 139, https:\/\/doi.org\/10.1186\/s12957-021-02253-y","DOI":"10.1186\/s12957-021-02253-y"},{"key":"87273_CR19","doi-asserted-by":"publisher","unstructured":"Zhang, L. et al. Prognostic Value of Albumin to D-Dimer Ratio in Advanced Gastric Cancer. J Oncol 9973743, (2021). https:\/\/doi.org\/10.1155\/2021\/9973743 (2021).","DOI":"10.1155\/2021\/9973743"},{"key":"87273_CR20","doi-asserted-by":"publisher","unstructured":"Falanga, A., Marchetti, M. & Vignoli, A. Coagulation and cancer: biological and clinical aspects. J. Thromb. Haemost 11, 223\u2013233, https:\/\/doi.org\/10.1111\/jth.12075","DOI":"10.1111\/jth.12075"},{"key":"87273_CR21","doi-asserted-by":"publisher","unstructured":"Fernandes, C. J. et al. Cancer-associated thrombosis: the when, how and why. Eur. Respir Rev. 28 https:\/\/doi.org\/10.1183\/16000617.0119-2018 (2019).","DOI":"10.1183\/16000617.0119-2018"},{"key":"87273_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1590\/1806-9282.66.5.649","volume":"66","author":"S Kalkan","year":"1992","unstructured":"Kalkan, S. & Caliskan, S. High D-dimer levels are associated with prostate cancer. Rev. Assoc. Med. Bras. 66, 649\u2013653. https:\/\/doi.org\/10.1590\/1806-9282.66.5.649 (1992). ).","journal-title":"Rev. Assoc. Med. Bras."},{"key":"87273_CR23","doi-asserted-by":"publisher","unstructured":"Li, B., Shou, Y. & Zhu, H. Predictive value of hemoglobin, platelets, and D-dimer for the surviva l of patients with stage IA1 to IIA2 cervical cancer: a retrospective study. J. Int. Med. Res. 49, 3000605211061008, https:\/\/doi.org\/10.1177\/03000605211061008","DOI":"10.1177\/03000605211061008"},{"key":"87273_CR24","doi-asserted-by":"publisher","first-page":"e0153514","DOI":"10.1371\/journal.pone.0153514","volume":"11","author":"D Han","year":"2016","unstructured":"Han, D. et al. Impact of D-Dimer for prediction of Incident Occult Cancer in patients with unprovoked venous thromboembolism. PLoS One. 11, e0153514. https:\/\/doi.org\/10.1371\/journal.pone.0153514 (2016).","journal-title":"PLoS One"},{"key":"87273_CR25","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1200\/jco.2000.18.3.600","volume":"18","author":"K Blackwell","year":"2000","unstructured":"Blackwell, K. et al. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status. J. Clin. Oncol. 18, 600\u2013608. https:\/\/doi.org\/10.1200\/jco.2000.18.3.600 (2000).","journal-title":"J. Clin. Oncol."},{"key":"87273_CR26","doi-asserted-by":"publisher","unstructured":"Heit, J. A. Cancer and venous thromboembolism: scope of the problem. Cancer Control 12 Suppl 1, 5\u201310, https:\/\/doi.org\/10.1177\/1073274805012003S02","DOI":"10.1177\/1073274805012003S02"},{"key":"87273_CR27","doi-asserted-by":"publisher","unstructured":"Ma, Y. Y. et al. Interaction of coagulation factors and tumor-associated macrophages me diates migration and invasion of gastric cancer. Cancer Sci. 102, 336\u2013342, https:\/\/doi.org\/10.1111\/j.1349-7006.2010.01795.x","DOI":"10.1111\/j.1349-7006.2010.01795.x"},{"key":"87273_CR28","doi-asserted-by":"publisher","unstructured":"Johns, C. et al. Aspirin use is Associated with Improved outcomes in Inflammatory Breas t Cancer patients. J. Breast Cancer 26, 14\u201324, https:\/\/doi.org\/10.4048\/jbc.2023.26.e3","DOI":"10.4048\/jbc.2023.26.e3"},{"key":"87273_CR29","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1182\/blood-2013-09-524108","volume":"123","author":"Z Zhou","year":"2014","unstructured":"Zhou, Z. et al. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the Rituximab era. Blood 123, 837\u2013842. https:\/\/doi.org\/10.1182\/blood-2013-09-524108 (2014).","journal-title":"Blood"},{"key":"87273_CR30","first-page":"475","volume":"13","author":"T Yu","year":"2023","unstructured":"Yu, T., Luo, D., Luo, C., Xu-Monette, Z. Y. & Yu, L. Prognostic and therapeutic value of serum lipids and a new IPI score system based on apolipoprotein A-I in diffuse large B-cell lymphoma. Am. J. Cancer Res. 13, 475\u2013484 (2023).","journal-title":"Am. J. Cancer Res."},{"key":"87273_CR31","doi-asserted-by":"publisher","unstructured":"Shibutani, M. et al. The significance of the D-Dimer level as a prognostic marker for Survi val and treatment outcomes in patients with stage IV Colorectal Cancer. In vivo (Athens Greece) 37, 440\u2013444, https:\/\/doi.org\/10.21873\/invivo.13097","DOI":"10.21873\/invivo.13097"},{"key":"87273_CR32","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3324\/haematol.2011.054718","volume":"97","author":"C Ay","year":"2012","unstructured":"Ay, C. et al. High D-dimer levels are associated with poor prognosis in cancer patients. Haematologica 97, 1158\u20131164. https:\/\/doi.org\/10.3324\/haematol.2011.054718 (2012).","journal-title":"Haematologica"},{"key":"87273_CR33","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1159\/000487734","volume":"45","author":"W Li","year":"2018","unstructured":"Li, W. et al. Prognostic role of pretreatment plasma D-Dimer in patients with solid tumors: a systematic review and Meta-analysis. Cell. Physiol. Biochem. 45, 1663\u20131676. https:\/\/doi.org\/10.1159\/000487734 (2018).","journal-title":"Cell. Physiol. Biochem."},{"key":"87273_CR34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.cca.2018.04.013","volume":"482","author":"B Liu","year":"2018","unstructured":"Liu, B. et al. Prognostic value of pretreatment plasma D-dimer levels in patients with diffuse large B cell lymphoma (DLBCL). Clin. Chim. Acta. 482, 191\u2013198. https:\/\/doi.org\/10.1016\/j.cca.2018.04.013 (2018).","journal-title":"Clin. Chim. Acta"},{"key":"87273_CR35","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.2147\/ott.S254514","volume":"13","author":"X Chen","year":"2020","unstructured":"Chen, X. et al. Prognostic value of the Preoperative plasma D-Dimer levels in patients with Upper Tract Urothelial Carcinoma in a Retrospective Cohort Study. Onco Targets Ther. 13, 5047\u20135055. https:\/\/doi.org\/10.2147\/ott.S254514 (2020).","journal-title":"Onco Targets Ther."},{"key":"87273_CR36","doi-asserted-by":"publisher","first-page":"e90547","DOI":"10.1371\/journal.pone.0090547","volume":"9","author":"L Liu","year":"2014","unstructured":"Liu, L. et al. Elevated plasma D-dimer levels correlate with long term survival of gastric cancer patients. PLoS One. 9, e90547. https:\/\/doi.org\/10.1371\/journal.pone.0090547 (2014).","journal-title":"PLoS One"},{"key":"87273_CR37","doi-asserted-by":"publisher","unstructured":"Morii, T., Mochizuki, K., Tajima, T., Ichimura, S. & Satomi, K. D-dimer levels as a prognostic factor for determining oncological outc omes in musculoskeletal sarcoma. BMC Musculoskelet. Disord 12, 250, https:\/\/doi.org\/10.1186\/1471-2474-12-250","DOI":"10.1186\/1471-2474-12-250"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87273-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87273-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87273-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T01:17:13Z","timestamp":1737681433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87273-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["87273"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-87273-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4540155\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"6 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This retrospective study was approved by the Ethics Committee of the Second Affiliated Hospital of Nanjing Medical University (approval number: 2023KY-13-01) and was conducted in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"3049"}}